STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Verrica Pharmaceuticals Inc.

Filed

December 19, 2023

Period of Report

December 15, 2023

Accession Number

0001062993-23-022861